Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016996229> ?p ?o ?g. }
- W2016996229 endingPage "266" @default.
- W2016996229 startingPage "258" @default.
- W2016996229 abstract "Both the p53- and E2F1-signaling pathways are defective in almost all types of tumors, suggesting very important roles for their signaling networks in regulating the process of tumorigenesis and therapy response. Studies on Radiation Therapy Oncology Group tissue samples have identified aberrant expression of p53, MDM2 (an E3 ubiquitin ligase that targets p53 for proteosomal degradation), and p16 (an upstream regulator of retinoblastoma and hence E2F1 in prostate cancer); abnormal expression of these biomarkers has been associated with clinical outcome after radiotherapy ± androgen deprivation therapy. Although the proapoptotic properties of p53 are well documented, a relatively new aspect of p53 function as an active mediator of prosurvival signaling pathways is now emerging. E2F1 is a transcription factor that possesses both proapoptotic and prosurvival properties. Thus, the role of E2F1 in the process of tumorigenesis versus apoptosis is a contested issue that needs to be resolved. Furthermore, the role of E2F1 in DNA repair is being increasingly recognized. Thus, novel approaches to curb the prosurvival and DNA repair capability of E2F1 while promoting apoptotic function are of interest. In this review, we discuss the challenges involved in targeting the p53/E2F1 pathways and the crosstalk networks, and further propose potential therapeutic strategies for prostate cancer management." @default.
- W2016996229 created "2016-06-24" @default.
- W2016996229 creator A5036656612 @default.
- W2016996229 creator A5063389942 @default.
- W2016996229 creator A5084025563 @default.
- W2016996229 creator A5086126549 @default.
- W2016996229 creator A5090919725 @default.
- W2016996229 date "2010-10-01" @default.
- W2016996229 modified "2023-10-06" @default.
- W2016996229 title "The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy" @default.
- W2016996229 cites W1520563041 @default.
- W2016996229 cites W1527149712 @default.
- W2016996229 cites W1616121322 @default.
- W2016996229 cites W1804201762 @default.
- W2016996229 cites W1986512406 @default.
- W2016996229 cites W1989168159 @default.
- W2016996229 cites W1990882829 @default.
- W2016996229 cites W1992708996 @default.
- W2016996229 cites W1993666315 @default.
- W2016996229 cites W1994381948 @default.
- W2016996229 cites W1995211857 @default.
- W2016996229 cites W1996632098 @default.
- W2016996229 cites W1997068466 @default.
- W2016996229 cites W1997387658 @default.
- W2016996229 cites W1999416824 @default.
- W2016996229 cites W2003239757 @default.
- W2016996229 cites W2008933923 @default.
- W2016996229 cites W2011708657 @default.
- W2016996229 cites W2011938148 @default.
- W2016996229 cites W2015322079 @default.
- W2016996229 cites W2019562165 @default.
- W2016996229 cites W2024386994 @default.
- W2016996229 cites W2029327556 @default.
- W2016996229 cites W2032109237 @default.
- W2016996229 cites W2038522365 @default.
- W2016996229 cites W2039692898 @default.
- W2016996229 cites W2041568308 @default.
- W2016996229 cites W2044992707 @default.
- W2016996229 cites W2046958356 @default.
- W2016996229 cites W2048981268 @default.
- W2016996229 cites W2049509123 @default.
- W2016996229 cites W2054264611 @default.
- W2016996229 cites W2060513486 @default.
- W2016996229 cites W2064676609 @default.
- W2016996229 cites W2069472546 @default.
- W2016996229 cites W2073425409 @default.
- W2016996229 cites W2074545297 @default.
- W2016996229 cites W2075213054 @default.
- W2016996229 cites W2080887232 @default.
- W2016996229 cites W2091145752 @default.
- W2016996229 cites W2099113454 @default.
- W2016996229 cites W2101801927 @default.
- W2016996229 cites W2103756564 @default.
- W2016996229 cites W2104220131 @default.
- W2016996229 cites W2104462038 @default.
- W2016996229 cites W2115272028 @default.
- W2016996229 cites W2116258646 @default.
- W2016996229 cites W2125538315 @default.
- W2016996229 cites W2128103722 @default.
- W2016996229 cites W2128365260 @default.
- W2016996229 cites W2128928089 @default.
- W2016996229 cites W2134430835 @default.
- W2016996229 cites W2135789424 @default.
- W2016996229 cites W2139466852 @default.
- W2016996229 cites W2142359566 @default.
- W2016996229 cites W2145847071 @default.
- W2016996229 cites W2146561872 @default.
- W2016996229 cites W2146948875 @default.
- W2016996229 cites W2148539277 @default.
- W2016996229 cites W2153964208 @default.
- W2016996229 cites W2154055662 @default.
- W2016996229 cites W2156712995 @default.
- W2016996229 cites W2157957734 @default.
- W2016996229 cites W2160345685 @default.
- W2016996229 cites W2162874742 @default.
- W2016996229 cites W2164819220 @default.
- W2016996229 cites W2165732124 @default.
- W2016996229 cites W2168084973 @default.
- W2016996229 cites W2327142738 @default.
- W2016996229 cites W2329991259 @default.
- W2016996229 doi "https://doi.org/10.1016/j.semradonc.2010.05.007" @default.
- W2016996229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20832018" @default.
- W2016996229 hasPublicationYear "2010" @default.
- W2016996229 type Work @default.
- W2016996229 sameAs 2016996229 @default.
- W2016996229 citedByCount "47" @default.
- W2016996229 countsByYear W20169962292012 @default.
- W2016996229 countsByYear W20169962292013 @default.
- W2016996229 countsByYear W20169962292014 @default.
- W2016996229 countsByYear W20169962292015 @default.
- W2016996229 countsByYear W20169962292016 @default.
- W2016996229 countsByYear W20169962292017 @default.
- W2016996229 countsByYear W20169962292019 @default.
- W2016996229 countsByYear W20169962292020 @default.
- W2016996229 countsByYear W20169962292021 @default.
- W2016996229 countsByYear W20169962292022 @default.
- W2016996229 countsByYear W20169962292023 @default.
- W2016996229 crossrefType "journal-article" @default.